7.88 USD
-0.18 (-2.23%)
7.68 USD
-0.2 (-2.54%)
Taking everything into account, KMDA scores 6 out of 10 in our fundamental rating. KMDA was compared to 528 industry peers in the Biotechnology industry. KMDA scores excellent on profitability, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on KMDA. These ratings could make KMDA a good candidate for value investing.
1. Profitability
1.1 Basic Checks
KMDA had positive earnings in the past year.
In the past year KMDA had a positive cash flow from operations.
In multiple years KMDA reported negative net income over the last 5 years.
Of the past 5 years KMDA 4 years had a positive operating cash flow.
1.2 Ratios
KMDA has a Return On Assets of 5.42%. This is amongst the best in the industry. KMDA outperforms 91.86% of its industry peers.
Looking at the Return On Equity, with a value of 7.72%, KMDA belongs to the top of the industry, outperforming 91.48% of the companies in the same industry.
The Return On Invested Capital of KMDA (6.67%) is better than 92.99% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KMDA is significantly below the industry average of 18.28%.
The 3 year average ROIC (2.97%) for KMDA is below the current ROIC(6.67%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.72% | ||
| ROIC | 6.67% |
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
1.3 Margins
KMDA's Profit Margin of 11.70% is amongst the best of the industry. KMDA outperforms 91.67% of its industry peers.
KMDA's Profit Margin has declined in the last couple of years.
The Operating Margin of KMDA (15.89%) is better than 93.56% of its industry peers.
KMDA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 43.75%, KMDA is in the better half of the industry, outperforming 74.43% of the companies in the same industry.
KMDA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.89% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% |
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), KMDA is destroying value.
The number of shares outstanding for KMDA has been increased compared to 1 year ago.
KMDA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, KMDA has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.60 indicates that KMDA is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.60, KMDA is doing good in the industry, outperforming 70.08% of the companies in the same industry.
The Debt to FCF ratio of KMDA is 0.59, which is an excellent value as it means it would take KMDA, only 0.59 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.59, KMDA belongs to the top of the industry, outperforming 95.08% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that KMDA is not too dependend on debt financing.
KMDA has a Debt to Equity ratio of 0.04. This is comparable to the rest of the industry: KMDA outperforms 42.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.59 | ||
| Altman-Z | 3.6 |
ROIC/WACC0.78
WACC8.52%
2.3 Liquidity
KMDA has a Current Ratio of 4.02. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
KMDA has a Current ratio (4.02) which is in line with its industry peers.
A Quick Ratio of 2.25 indicates that KMDA has no problem at all paying its short term obligations.
KMDA's Quick ratio of 2.25 is on the low side compared to the rest of the industry. KMDA is outperformed by 70.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.02 | ||
| Quick Ratio | 2.25 |
3. Growth
3.1 Past
KMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.57%, which is quite impressive.
KMDA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.60% yearly.
Looking at the last year, KMDA shows a quite strong growth in Revenue. The Revenue has grown by 10.36% in the last year.
Measured over the past years, KMDA shows a small growth in Revenue. The Revenue has been growing by 4.82% on average per year.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
3.2 Future
Based on estimates for the next years, KMDA will show a very strong growth in Earnings Per Share. The EPS will grow by 29.48% on average per year.
Based on estimates for the next years, KMDA will show a quite strong growth in Revenue. The Revenue will grow by 10.31% on average per year.
EPS Next Y44.17%
EPS Next 2Y31.88%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue Next Year12.37%
Revenue Next 2Y11.55%
Revenue Next 3Y10.31%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 21.89, the valuation of KMDA can be described as rather expensive.
Based on the Price/Earnings ratio, KMDA is valued cheaply inside the industry as 94.32% of the companies are valued more expensively.
KMDA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
KMDA is valuated rather expensively with a Price/Forward Earnings ratio of 17.43.
KMDA's Price/Forward Earnings ratio is rather cheap when compared to the industry. KMDA is cheaper than 94.89% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of KMDA to the average of the S&P500 Index (23.98), we can say KMDA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.89 | ||
| Fwd PE | 17.43 |
4.2 Price Multiples
KMDA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. KMDA is cheaper than 97.35% of the companies in the same industry.
KMDA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KMDA is cheaper than 94.51% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.24 | ||
| EV/EBITDA | 9.39 |
4.3 Compensation for Growth
KMDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of KMDA may justify a higher PE ratio.
KMDA's earnings are expected to grow with 29.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y31.88%
EPS Next 3Y29.48%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.49%, KMDA has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.26, KMDA pays a better dividend. On top of this KMDA pays more dividend than 98.48% of the companies listed in the same industry.
KMDA's Dividend Yield is a higher than the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.49% |
5.2 History
KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y31.88%
EPS Next 3Y29.48%
7.88
-0.18 (-2.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners11.42%
Inst Owner Change0%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap454.52M
Revenue(TTM)174.79M
Net Income(TTM)20.45M
Analysts84.44
Price Target13.26 (68.27%)
Short Float %0.24%
Short Ratio0.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.49% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.52%
Min EPS beat(2)-4.61%
Max EPS beat(2)45.66%
EPS beat(4)3
Avg EPS beat(4)17.85%
Min EPS beat(4)-4.61%
Max EPS beat(4)45.66%
EPS beat(8)6
Avg EPS beat(8)19.32%
EPS beat(12)9
Avg EPS beat(12)7.95%
EPS beat(16)10
Avg EPS beat(16)-82.64%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)1.07%
PT rev (1m)-11.86%
PT rev (3m)-18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.5%
EPS NY rev (1m)2.08%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.89 | ||
| Fwd PE | 17.43 | ||
| P/S | 2.6 | ||
| P/FCF | 24.24 | ||
| P/OCF | 15.67 | ||
| P/B | 1.72 | ||
| P/tB | 1.93 | ||
| EV/EBITDA | 9.39 |
EPS(TTM)0.36
EY4.57%
EPS(NY)0.45
Fwd EY5.74%
FCF(TTM)0.33
FCFY4.13%
OCF(TTM)0.5
OCFY6.38%
SpS3.03
BVpS4.59
TBVpS4.07
PEG (NY)0.5
PEG (5Y)N/A
Graham Number6.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.72% | ||
| ROCE | 8.44% | ||
| ROIC | 6.67% | ||
| ROICexc | 8.54% | ||
| ROICexgc | 9.66% | ||
| OM | 15.89% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% | ||
| FCFM | 10.73% |
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
ROICexc(3y)3.77%
ROICexc(5y)N/A
ROICexgc(3y)8.9%
ROICexgc(5y)N/A
ROCE(3y)3.76%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.21%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.77%
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.59 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 67.04% | ||
| Cap/Sales | 5.86% | ||
| Interest Coverage | 35.6 | ||
| Cash Conversion | 67.35% | ||
| Profit Quality | 91.69% | ||
| Current Ratio | 4.02 | ||
| Quick Ratio | 2.25 | ||
| Altman-Z | 3.6 |
F-Score7
WACC8.52%
ROIC/WACC0.78
Cap/Depr(3y)51.55%
Cap/Depr(5y)66.64%
Cap/Sales(3y)4.62%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y44.17%
EPS Next 2Y31.88%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.37%
Revenue Next 2Y11.55%
Revenue Next 3Y10.31%
Revenue Next 5YN/A
EBIT growth 1Y56.49%
EBIT growth 3YN/A
EBIT growth 5Y-2.59%
EBIT Next Year134.37%
EBIT Next 3Y44.92%
EBIT Next 5YN/A
FCF growth 1Y941.67%
FCF growth 3YN/A
FCF growth 5Y7.92%
OCF growth 1Y336.09%
OCF growth 3YN/A
OCF growth 5Y11.73%
KAMADA LTD / KMDA FAQ
Can you provide the ChartMill fundamental rating for KAMADA LTD?
ChartMill assigns a fundamental rating of 6 / 10 to KMDA.
What is the valuation status for KMDA stock?
ChartMill assigns a valuation rating of 7 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.
Can you provide the profitability details for KAMADA LTD?
KAMADA LTD (KMDA) has a profitability rating of 7 / 10.
How financially healthy is KAMADA LTD?
The financial health rating of KAMADA LTD (KMDA) is 6 / 10.